XML 37 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Note 9 - Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
9
.
Fair Value of Financial Instruments
 
The carrying value of cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses and other current liabilities approximates fair value due to the relatively short maturity of these instruments. Common stock warrants which are classified as a liability are recorded at their fair market value as of each reporting period.
 
The measurement of fair value requires the use of techniques based on observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. The inputs create the following fair value hierarchy:
 
 
Level
1
– Quoted prices for identical instruments in active markets.
 
 
Level
2
– Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are
not
active; and model-derived valuations where inputs are observable or where significant value drivers are observable.
 
 
Level
3
– Instruments where significant value drivers are unobservable to
third
parties.
 
The Company uses model-derived valuations where certain inputs are unobservable to
third
parties to determine the fair value of certain common stock warrants on a recurring basis and classifies such liability-classified warrants in Level
3.
As described in
Note
7
, the fair value of the liability classified warrant was
$6.1
million
 at
March 31, 2020
.
 
There were
no
transfers between levels of the fair value hierarchy for the
three
months ended
March 31, 2020
. As of
March 31, 2020
and
December 31, 2019,
the Company had approximately
$58.7
million and
$56.7
million, respectively, of cash equivalents classified as Level
1
financial instruments. There were
no
Level
2
financial instruments as of
March 31, 2020.
As of
December 31, 2019,
the Company had approximately
$5.6
million and
$90.0
million of restricted cash equivalents classified as Level
1
and Level
2
financial instruments, respectively. 
 
The following table presents changes in the liability-classified warrant measured at fair value using Level
3
inputs:
 
   
Fair Value Measurements of Level 3 liability-classified warrant
 
Warrant liability at December 31, 2019
  $
6,116,882
 
Increase in fair value of warrant liability
   
16,065
 
Exercise of warrants
   
 
Warrant liability at March 31, 2020
  $
6,132,947